Blog
RSS FeedPosted by Michael Wonder on 04 Dec 2022
PHARMAC seeking feedback on funding Trikafta
4 December 2022 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund Trikafta. ...
Posted by Michael Wonder on 01 Dec 2022
‘Good news’ for Kiwi women as PHARMAC funds Utrogestan from today
1 December 2022 - The end of a decade long wait. ...
Posted by Michael Wonder on 30 Nov 2022
New Zealand Pharmaceutical Schedule - 1 December 2022
1 December 2022 - The December 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Nov 2022
The Government may have taken money from the DHB hospital budget to increase PHARMAC's funding
30 November 2022 - In this year’s budget, the Government said it has increased PHARMAC's funding by 43% over the ...
Posted by Michael Wonder on 27 Nov 2022
The cruellest tax: clipping the ticket on unfunded cancer drugs
28 November 2022 - Jo McKenzie-McLean’s life was turned upside down after a stage 4 bowel cancer diagnosis. ...
Posted by Michael Wonder on 24 Nov 2022
GPs can't prescribe ADHD medication, some say that's a problem
24 November 2022 - When Ben Mitchell was first diagnosed with attention deficit hyperactivity disorder (ADHD), he waited four months to ...
Posted by Michael Wonder on 21 Nov 2022
Kiwi myeloma cancer sufferers don’t have access to daratumumab, a drug available in Australia
21 November 2022 - Kiwi cancer sufferers are being denied a drug that saves lives in other countries, including Australia ...
Posted by Michael Wonder on 21 Nov 2022
'Heartbreaking': parents of sick 11 month old want greater meningitis awareness
19 November 2022 - A cough quickly turned into a “horrible” few weeks for an Auckland family whose infant son ...
Posted by Michael Wonder on 20 Nov 2022
PHARMAC welcomes Myeloma NZ as first patient advocacy group to present to PTAC
21 November 2022 - Myeloma New Zealand presented directly to PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making ...
Posted by Michael Wonder on 20 Nov 2022
PHARMAC calls for applications for medicines for rare disorders
21 November 2022 - PHARMAC is calling for applications for medicines for rare disorders. ...
Posted by Michael Wonder on 18 Nov 2022
Diabetic accuses PHARMAC of faulty analysis of glucose monitors
17 November 2022 - Insulin-dependent diabetics say PHARMAC's decision to delay funding a potentially life-saving device appears to be based ...
Posted by Michael Wonder on 15 Nov 2022
Expansion of access to MenB vaccine urgently needed
15 November 2022 - Meningococcal B is a rare but very serious disease, causing death and serious long-term disabilities. Even when ...
Posted by Michael Wonder on 10 Nov 2022
Decision to fund long-acting paliperidone for people with schizophrenia and ibrutinib for people with chronic lymphocytic leukaemia
10 November 2022 - PHARMAC is pleased to announce a decision to fund two new medicines. ...
Posted by Michael Wonder on 10 Nov 2022
Decision to fund vedolizumab for inflammatory bowel disease and brentuximab for rare lymphomas
10 November 2022 - PHARMAC is pleased to announce a decision to fund two new treatments: vedolizumab for inflammatory bowel ...
Posted by Michael Wonder on 07 Nov 2022
PHARMAC widens access to pneumococcal vaccine
7 November 2022 - PHARMAC has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (Prevenar ...